VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

EAN 2020 | Neurological risks of laughing gas abuse

Anne Bruijnes • 1 Jun 2020
EAN 2020
General
Perspectives

Anne Bruijnes, MD, Zuyderland Medical Center, Heerlen, The Netherlands, discusses the neurological outcomes associated with recreational use of laughing gas (nitrous oxide). This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

Related Videos

1:49
How dose and regimen impact levodopa bioavailability
Joaquim Ferreira • 29 Aug 2023
2:24
The importance of clinical trials in generating evidence for safe and effective therapies
Joaquim Ferreira • 29 Aug 2023
1:19
Combining non-pharmacological treatments with pharmacotherapies for PD
Joaquim Ferreira • 29 Aug 2023
1:27
Bridging gaps and embracing AI: goals of the EAN Congress
Laszlo Csiba • 3 Jul 2023
The content of VJNeurology is intended for healthcare professionals